Merck receives EU marketing authorization for Mycoplasma hyopneumoniae vaccine

Merck Animal Health (MSD Animal Health outside the USA and Canada) has received marketing authorization in the European Union for PORCILIS M Hyo ID ONCE, a single-shot vaccine against Mycoplasma hyopneumoniae infection in pigs for intradermal administration.

PORCILIS M Hyo ID ONCE is approved in the 25 member states of the EU plus Iceland and Norway for the active immunization of finishing pigs to reduce pulmonary lesions and the decrease in daily weight gain during the finishing period due to infection caused by M Hyo.